Intrapartum and postpartum antibiotic use in seven low‐ and middle‐income countries: Findings from the A‐PLUS trial
BJOG: An International Journal of Obstetrics & Gynaecology · 2025
DOI: 10.1111/1471-0528.17930 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2025. Verfasst von Sarah Saleem und 31 weiteren Autor:innen. Beteiligte Einrichtung: Aga Khan University, Karachi, Pakistan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Developing Countries, Azithromycin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Bill and Melinda Gates Foundation, National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Objective
To describe the intrapartum and postpartum use of non‐study antibiotics in low‐ and middle‐income countries (LMICs) during the double‐blinded NICHD Global Network Azithromycin in Labor (A‐PLUS) trial.
Design
The antibiotic use sub‐study was a planned prospective, observational sub‐study of the A‐PLUS trial. Settings The study was carried out in hospitals or health centres affiliated with eight sites of the Global Network for Women's and Children's Health Research (Global Network) in seven countries: Bangladesh, Pakistan, India (two sites), Kenya, Zambia, The Democratic Republic of the Congo (DRC) and Guatemala. Population Totally, 29 278 pregnant women enrolled in the A‐PLUS trial.
Methods
We collected data on 29 278 pregnant women admitted to a facility for delivery related to non‐study antibiotic use overall and during three time periods: (1) in the facility prior to delivery, (2) after delivery until facility discharge and (3) after discharge to 42 days post‐partum. Main Outcome Measures Non‐study antibiotic use overall and for treatment or prophylaxis by the site during the three time periods.
Results
Of the 29 278 women in the study, 5020 (17.1%; 95% CI 16.7%–17.6%) received non‐study antibiotics in the facility prior to delivery, 11 956 (40.8%; 95% CI 40.3%–41.4%) received non‐study antibiotics in the facility after delivery, and 13 390 (47.6%; 95% CI 47.0%–48.2%) women received non‐study antibiotics after delivery and after facility discharge. Antibiotics were prescribed more often among women in the Asian and Guatemalan sites than in the African sites. In the three time‐periods, among those receiving antibiotics, prophylaxis was the indication in 82.3%, 97.7% and 90.7% of the cases, respectively. The type of antibiotics used varied substantially by time‐period and site, but generally, penicillin‐type drugs, cephalosporin‐type drugs and metronidazole were used more frequently than other types.
Conclusions
Across the eight sites of the Global Network, in the facility before delivery, and in the post‐partum periods before and after facility discharge, antibiotics were used frequently, but use was highly variable by site and time‐period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aga Khan University, Karachi, Pakistan.
- Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
- RTI International, Durham, North Carolina, USA.
- Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- University of Zambia University Teaching Hospital, Lusaka, Zambia.
ORCID-Profile: Avinash Kavi, Archana Patel, Sk Masum Billah, Elizabeth M McClure
Förderung
- NICHD NIH HHS
- Bill and Melinda Gates Foundation
- National Institute of Child Health and Human Development
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Saleem, S., Yasmin, H., Moore, J. L., Rahim, A., Shakeel, I., Lokangaka, A., Tshefu, A., Bauserman, M., Mwenechanya, M., Chomba, E., Goudar, S. S., Kavi, A., Derman, R. J., Krebs, N. F., Figueroa, L., Mazariegos, M., Nyongesa, P., Bucher, S., Esamai, F., …, & Goldenberg, R. L. (2025). Intrapartum and postpartum antibiotic use in seven low‐ and middle‐income countries: Findings from the A‐PLUS trial. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17930
Vancouver
Saleem S, Yasmin H, Moore JL, Rahim A, Shakeel I, Lokangaka A, et al. Intrapartum and postpartum antibiotic use in seven low‐ and middle‐income countries: Findings from the A‐PLUS trial. BJOG: An International Journal of Obstetrics & Gynaecology. 2025. doi:10.1111/1471-0528.17930
BibTeX
@article{Saleem2025,
author = {Saleem, Sarah and Yasmin, Haleema and Moore, Janet L and Rahim, Anum and Shakeel, Iram and Lokangaka, Adrien and Tshefu, Antoinette and Bauserman, Melissa and Mwenechanya, Musaku and Chomba, Elwyn and Goudar, Shivaprasad S and Kavi, Avinash and Derman, Richard J and Krebs, Nancy F and Figueroa, Lester and Mazariegos, Manolo and Nyongesa, Paul and Bucher, Sherri and Esamai, Fabian and Patel, Archana and Waikar, Manjushree and Shivkumar, Poonam and Hibberd, Patricia L and Petri, William A and Billah, Sk Masum and Haque, Rashidul and Carlo, Waldemar A and Tita, Alan and Koso-Thomas, Marion and Hemingway-Foday, Jennifer and McClure, Elizabeth M and Goldenberg, Robert L},
title = {Intrapartum and postpartum antibiotic use in seven low‐ and middle‐income countries: Findings from the A‐PLUS trial},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2025},
doi = {10.1111/1471-0528.17930}
}
EUVIMED